The neuroendocrine-appetite-mental health triangle in PMOS: Implications for GLP-1 receptor agonist therapy

Wenting Xu, Chao Lu, Jie Xu, Lihong Wang

Open source

DOI
10.1016/j.neubiorev.2026.106846
Published
2026-10
Container
Neuroscience & Biobehavioral Reviews
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.neubiorev.2026.106846,
  title = {The neuroendocrine-appetite-mental health triangle in PMOS: Implications for GLP-1 receptor agonist therapy},
  author = {Wenting Xu and Chao Lu and Jie Xu and Lihong Wang},
  year = {2026},
  journal = {Neuroscience \& Biobehavioral Reviews},
  doi = {10.1016/j.neubiorev.2026.106846},
  url = {https://doi.org/10.1016/j.neubiorev.2026.106846}
}

RIS

TY  - JOUR
TI  - The neuroendocrine-appetite-mental health triangle in PMOS: Implications for GLP-1 receptor agonist therapy
AU  - Wenting Xu
AU  - Chao Lu
AU  - Jie Xu
AU  - Lihong Wang
PY  - 2026
JO  - Neuroscience & Biobehavioral Reviews
DO  - 10.1016/j.neubiorev.2026.106846
UR  - https://doi.org/10.1016/j.neubiorev.2026.106846
ER  - 

APA

Xu, W., Lu, C., Xu, J., & Wang, L. (2026). The neuroendocrine-appetite-mental health triangle in PMOS: Implications for GLP-1 receptor agonist therapy. Neuroscience & Biobehavioral Reviews. https://doi.org/10.1016/j.neubiorev.2026.106846

Source records